Pfizer CRZ 250 (Xalkori 250 mg)
Generic Name: crizotinib
This pill with imprint "Pfizer CRZ 250" is Pink, Capsule-shape and has been identified as Xalkori 250 mg. It is supplied by Pfizer Inc..
Xalkori is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Xalkori 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
Xalkori
- Generic Name:
- crizotinib
- Imprint:
- Pfizer CRZ 250
- Strength:
- 250 mg
- Color:
- Pink
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Multikinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Pfizer Inc.
- National Drug Code (NDC):
- 00069-8140
More about Xalkori (crizotinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 2 Reviews – Add your own review/rating
- Drug class: multikinase inhibitors
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
